Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Neoadjuvant therapy (NAT) is increasingly used to treat patients with pancreatic ductal adenocarcinoma (PDAC). Patients with PDAC often show heterogenous responses to NAT with variable clinical outcomes, and the clinicopathologic parameters associated with these variable outcomes remain unclear. In...

Full description

Bibliographic Details
Main Authors: Tom Z. Liang, Matthew H. G. Katz, Laura R. Prakash, Deyali Chatterjee, Hua Wang, Michael Kim, Ching-Wei D. Tzeng, Naruhiko Ikoma, Robert A. Wolff, Dan Zhao, Eugene J. Koay, Anirban Maitra, Suprateek Kundu, Huamin Wang
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
pancreatic cancer
neoadjuvant therapy
tumor response grade
tumor stage
lymph node metastasis
long-term survivors
Online Access:https://www.mdpi.com/2072-6694/15/12/3231

Internet

https://www.mdpi.com/2072-6694/15/12/3231

Similar Items